A major advance in cancer research is occurring with the use of nanobodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in various types of cancer, leading uncontrolled https://bookmarkspecial.com/story22133183/vhh-fragments-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-management